Hayley Whitaker

Mobile DNA in cancer. Extensive transduction of nonrepetitive DNA mediated by L1 retrotransposition in cancer genomes.

Origins and functional consequences of somatic mitochondrial DNA mutations in human cancer.

Epigenetic and oncogenic regulation of SLC16A7 (MCT2) results in protein over-expression, impacting on signalling and cellular phenotypes in prostate cancer.

The Early Effects of Rapid Androgen Deprivation on Human Prostate Cancer.

Whole blood mRNA in prostate cancer reveals a four-gene androgen regulated panel.

HNF1B variants associate with promoter methylation and regulate gene networks activated in prostate and ovarian cancer.

Apparatus for Histological Validation of and Magnetic Resonance Imaging of the Human Prostate.

Appraising the relevance of DNA copy number loss and gain in prostate cancer using whole genome DNA sequence data.

Sequencing of prostate cancers identifies new cancer genes, routes of progression and drug targets.

Using antibody directed phototherapy to target oesophageal adenocarcinoma with heterogeneous HER2 expression.

Immunohistochemical biomarker validation in highly selective needle biopsy microarrays derived from mpMRI-characterized prostates.

VERDICT MRI validation in fresh and fixed prostate specimens using patient-specific moulds for histological and MR alignment.

PEOPLE: PatiEnt prOstate samPLes for rEsearch, a tissue collection pathway utilizing magnetic resonance imaging data to target tumor and benign tissue in fresh radical prostatectomy specimens.

VERDICT MRI for Prostate Cancer: Intracellular Volume Fraction versus Apparent Diffusion Coefficient.

Stroma in normal and cancer wound healing.

A Four-Group Urine Risk Classifier for Predicting Outcome in Prostate Cancer Patients.

The Oncogene Metadherin Interacts with the Known Splicing Proteins YTHDC1, Sam68 and T-STAR and Plays a Novel Role in Alternative mRNA Splicing.